Tatchempharmpreparaty

CompanyRussia

Tatchempharmpreparaty develops one asset, in phase 3 (Dimephosphon in acute stroke). Mostly small molecule; based in Russia.

1
Asset
Furthest stage
Phase 3
1
Trial
0
Signals

Pipeline

1
  • Dimephosphon

    Regulates acid-base balance and cerebral hemodynamics in ischemic stroke

    Phase 3, Small molecule, acute stroke, cerebrovascular disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Similar companies6

Intelligence